NDC 13533-692

Plasbumin

Albumin (human)

Plasbumin is a Intravenous Solution in the Plasma Derivative category. It is labeled and distributed by Grifols Usa, Llc. The primary component is Albumin Human.

• Product ID: 13533-692_08bdb639-6593-474a-8939-1a201797b11f
• NDC: 13533-692
• Product Type: Plasma Derivative
• Proprietary Name: Plasbumin
• Generic Name: Albumin (human)
• Dosage Form: Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 1994-09-26
• Marketing Category: BLA / BLA
• Application Number: BLA101138
• Labeler Name: GRIFOLS USA, LLC
• Substance Name: ALBUMIN HUMAN
• Active Ingredient Strength: 5 g/20mL
• Pharm Classes: Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 13533-692-16

1 VIAL in 1 CARTON (13533-692-16) > 20 mL in 1 VIAL (13533-692-17)

• Marketing Start Date: 1994-09-26
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 13533-692-17 [13533069217]

Plasbumin SOLUTION

• Marketing Category: BLA
• Application Number: BLA101138
• Product Type: PLASMA DERIVATIVE
• Billing Unit: ML
• Marketing Start Date: 2012-12-01

NDC 13533-692-72 [13533069272]

Plasbumin SOLUTION

• Marketing Category: BLA
• Application Number: BLA101138
• Product Type: PLASMA DERIVATIVE
• Billing Unit: ML
• Marketing Start Date: 2012-12-01

NDC 13533-692-21 [13533069221]

Plasbumin SOLUTION

• Marketing Category: BLA
• Application Number: BLA101138
• Product Type: PLASMA DERIVATIVE
• Billing Unit: ML
• Marketing Start Date: 2012-12-01

NDC 13533-692-71 [13533069271]

Plasbumin SOLUTION

• Marketing Category: BLA
• Application Number: BLA101138
• Product Type: PLASMA DERIVATIVE
• Billing Unit: ML
• Marketing Start Date: 1994-09-26

NDC 13533-692-16 [13533069216]

Plasbumin SOLUTION

• Marketing Category: BLA
• Application Number: BLA101138
• Product Type: PLASMA DERIVATIVE
• Billing Unit: ML
• Marketing Start Date: 1994-09-26

NDC 13533-692-20 [13533069220]

Plasbumin SOLUTION

• Marketing Category: BLA
• Application Number: BLA101138
• Product Type: PLASMA DERIVATIVE
• Billing Unit: ML
• Marketing Start Date: 1994-09-26

Drug Details

Active Ingredients

Ingredient	Strength
ALBUMIN HUMAN	5 g/20mL

Pharmacological Class

• Human Serum Albumin [EPC]
• Increased Intravascular Volume [PE]
• Increased Oncotic Pressure [PE]
• Osmotic Activity [MoA]
• Serum Albumin [Chemical/Ingredient]

Medicade Reported Pricing

13533069271 PLASBUMIN-25 IV SOLUTION

Pricing Unit: ML | Drug Type:

NDC Crossover Matching brand name "Plasbumin" or generic name "Albumin (human)"

NDC	Brand Name	Generic Name
13533-683	Plasbumin	Albumin (Human)
13533-684	Plasbumin	Albumin (Human)
13533-690	Plasbumin	Albumin (Human)
13533-691	Plasbumin	Albumin (Human)
13533-692	Plasbumin	Albumin (Human)
0053-7680	Albuminar-25	Albumin (Human)
0053-7670	Albuminar-5	Albumin (Human)
44206-251	AlbuRx	ALBUMIN (HUMAN)
44206-310	ALBURX	ALBUMIN (HUMAN)
68516-5214	ALBUTEIN	ALBUMIN (HUMAN)
68516-5215	ALBUTEIN	ALBUMIN (HUMAN)
68516-5216	ALBUTEIN	ALBUMIN (HUMAN)
61953-0001	HUMAN ALBUMIN GRIFOLS	ALBUMIN (HUMAN)
61953-0002	HUMAN ALBUMIN GRIFOLS	ALBUMIN (HUMAN)